Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5TWU

Structure of Maternal Embryonic Leucine Zipper Kinase

Summary for 5TWU
Entry DOI10.2210/pdb5twu/pdb
Related5TVT 5TWL 5TWY 5TWZ
DescriptorMaternal embryonic leucine zipper kinase (2 entities in total)
Functional Keywordskinase inhibitor, basal-like breast cancer, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight79313.91
Authors
Li, Q.,Seo, H.-S.,Huang, H.-T.,Gray, N.S.,Dhe-Paganon, S.,Eck, M.J. (deposition date: 2016-11-14, release date: 2017-11-22, Last modification date: 2023-10-04)
Primary citationHuang, H.T.,Seo, H.S.,Zhang, T.,Wang, Y.,Jiang, B.,Li, Q.,Buckley, D.L.,Nabet, B.,Roberts, J.M.,Paulk, J.,Dastjerdi, S.,Winter, G.E.,McLauchlan, H.,Moran, J.,Bradner, J.E.,Eck, M.J.,Dhe-Paganon, S.,Zhao, J.J.,Gray, N.S.
MELK is not necessary for the proliferation of basal-like breast cancer cells.
Elife, 6:-, 2017
Cited by
PubMed Abstract: Thorough preclinical target validation is essential for the success of drug discovery efforts. In this study, we combined chemical and genetic perturbants, including the development of a novel selective maternal embryonic leucine zipper kinase (MELK) inhibitor HTH-01-091, CRISPR/Cas9-mediated MELK knockout, a novel chemical-induced protein degradation strategy, RNA interference and CRISPR interference to validate MELK as a therapeutic target in basal-like breast cancers (BBC). In common culture conditions, we found that small molecule inhibition, genetic deletion, or acute depletion of MELK did not significantly affect cellular growth. This discrepancy to previous findings illuminated selectivity issues of the widely used MELK inhibitor OTSSP167, and potential off-target effects of MELK-targeting short hairpins. The different genetic and chemical tools developed here allow for the identification and validation of any causal roles MELK may play in cancer biology, which will be required to guide future MELK drug discovery efforts. Furthermore, our study provides a general framework for preclinical target validation.
PubMed: 28926338
DOI: 10.7554/eLife.26693
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.603 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon